China’s A‑Shares Surge: Pharma’s Innovation‑Drug Rally Fuels Gains
China’s A‑share market rises on 13 Aug, driven by pharma innovation. Harbin Gloria, a steady mid‑cap, stands to gain from the sector’s bullish trend and strong R&D pipeline.
4 minutes to read